Status:

COMPLETED

Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix

Lead Sponsor:

Thomas Jefferson University

Conditions:

Premature Birth

Eligibility:

FEMALE

18-50 years

Phase:

PHASE4

Brief Summary

The aim of this study is to evaluate the efficacy of cervical cerclage in prevention of spontaneous preterm birth in singleton pregnancies with a short transvaginal cervical length (\<=25mm) and witho...

Detailed Description

Singleton pregnancies between 18 0/7 to 23 6/7 weeks without a prior spontaneous preterm birth found to have a short transvaginal ultrasound cervical length (\<=25mm) and meeting all other eligibility...

Eligibility Criteria

Inclusion

  • 18 year old or older
  • Singleton pregnancy
  • No prior SPTB or second trimester losses between 160 and 366 weeks
  • TVU CL ≤25mm between 180 and 236 weeks

Exclusion

  • Multiple pregnancy
  • Prior SPTB or second trimester losses between 160 and 366 weeks
  • Cerclage in situ
  • Painful regular uterine contraction and/or preterm labor
  • Rupture membranes
  • Major fetal anomaly or aneuploidy
  • Active vaginal bleeding
  • Placenta previa and/or accreta
  • Cervical dilation \>1.0 cm and/or visible membranes by pelvic exam
  • Suspicion of chorioamnionitis

Key Trial Info

Start Date :

September 22 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 20 2024

Estimated Enrollment :

93 Patients enrolled

Trial Details

Trial ID

NCT03251729

Start Date

September 22 2017

End Date

February 20 2024

Last Update

April 19 2024

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States, 19107

2

University of Naples Federico II

Naples, Italy

3

University Cattolica del S. Cuore

Rome, Italy